Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 175 for “"HDAC Inhibitor"”.
-
An improved synthesis of the HDAC inhibitor trichostatin A
Histone deacetylase inhibitors (HDIs) have found a wide variety of medicinal uses and are most noted for their specific apoptotic action towards cancer cells. Several hydroxamate HDIs have since been moved on to phase 1 and 2 clinical drug trials, with one having already been approved for treatment …
-
Genomic Analysis of Chemo-Resistance to HDAC inhibitor in Gastric Cancer cells
Histone deacetylase inhibitors (HDACis) are a promising class of anticancer epigenetic drugs, however, molecular factors influencing the responses of individual tumors to HDACi therapies remain obscure. Here, we sought to identify genes associated with HDACi resistance in gastric cancer. Treating a …
-
OVERRIDING CISPLATIN RESISTANCE IN LUNG SQUAMOUS CELL CARCINOMA: INSIGHTS FROM COMBINATION WITH HDAC INHIBITOR
… SHOWN TO CONFER CISPLATIN RESISTANCE, WHILE MEK INHIBITORS AND BELINOSTAT AUGMENTED CISPLATIN SENSITIVITY IN SCC CELLS THROUGH INHIBITION OF MAPK/ERK SIGNALLING. PARALLEL INVESTIGATIONS SHOWED THAT BELINOSTAT POTENTIATED CISPLATIN-INDUCED APOPTOSIS IN SCC CELLS HARBOURING TP53 MUTATION. THIS CELL …
-
Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment
… in tumourigenesis. Histone deacetylases (HDACs) are enzymes that regulate acetylation of chromatin and a variety of other non-histone substrates. Significantly, HDAC inhibitors are potent anti-proliferative agents and exhibit clinical activity in lymphoproliferative and haematological …
-
Acetazolamide potentiates the anti-tumor efficacy of sulforaphane and HDAC inhibitor, MS-275, on bronchial carcinoids and neuroblastoma
Bronchial carcinoids (BC) and neuroblastoma (NB) are subgroups of neuroendocrine tumors of the lung and peripheral nervous system, respectively. BC present mainly in adults, and NB in children. BC accounts for 1–5% of all invasive lung malignancies and the atypical variant has a poor prognosis. NB …
-
Facilitation of Human Induced Pluripotent Stem (iPS) Cell Differentiation to Endoderm with a Novel Histone Deacetylase (HDAC) Inhibitor
… the engineering process. Histone deacetylase inhibitors (HDACi) alter gene transcription by inhibiting the deacetylation of lysine residues and have been reported to induce differentiation of cancer stem cells (Botrugno, Santoro, & Minucci, 2009). We are evaluating the ability of a novel HDACi …
-
The Effect of HDAC Inhibitor MI192 on Stem Cell Behaviour- The Potential of Utilising MI192 for Bone Tissue Engineering
… drawbacks and limitations. Histone deacetlyase (HDAC) proteins are key to cellular epigenetics, and a number of studies have shown that their inhibitors (HDACis) can control stem cell fate. The aim of this study was to investigate the effect of a novel HDAC2 and HDAC3 selective inhibitor, MI192, …
-
A Novel Therapeutic Strategy for Alzheimer’s Disease: Sex-Dependent Mechanisms Altered by the HDAC Inhibitor RG2833 in a Transgenic Rat Model
… This drug inhibits histone deacetylases (HDAC) 1 and 3 and exhibits both neuroprotective and anti-inflammatory properties. The overall GOAL of my studies was to understand the effects of HDAC inhibition on the neuromodulatory and neuroplasticity pathways relevant to AD. My central …
-
Neurogenesis and Neuroprotection in Huntington Disease
… cells in skeletal muscle, and the role of HDAC inhibitors (histone deacetylase inhibitors) in promoting neurogenesis, and increasing of neuronal proliferation, a combination of FGF6 with HDAC inhibitor CHDI-3 is investigated as a potential treatment to lessen neuronal loss in HD, by …
-
Translational Studies of Epigenetic Interventions for Post-Traumatic Epilepsy
… can be easily manipulated with the use of HDAC inhibitors which block the removal of acetyl groups from histone proteins, thereby affecting gene transcription. Previous research using HDAC inhibitor compounds have reported neuroprotective effects such as reduction of both inflammation and …
-
Part 1 Synthesis of a potent histone deacetylase inhibitor; Part 2 Studies towards a stabilized helix-turn-helix peptide
… the synthesis of a new histone deacetylase (HDAC) inhibitor (HDI). HDAC enzymes modify core histones, influence nucleosome structure and change gene transcription by removing the acetyl groups from lysine residues on proteins. HDIs are showing exciting potential as a new class of drugs for …
-
Butyrate, A Major Bacterial-derived Metabolite: Understanding of Butyrate Metabolism in Cancerous Colonocytes
… effects in colorectal cancer, is its role as an HDAC inhibitor. Moreover, it has been suggested that the metabolic fate of butyrate is significantly related to its role as an HDAC inhibitor. Therefore, understanding butyrate metabolism in cancerous colonocytes sheds important light on how …
-
Role of histone deacetylase 9 in pro inflammatory responses in monocytes and macrophages
Background: The histone deacetylase 9 (HDAC9) gene region on chromosome 7p21.1 has been identified as a major risk locus for large-vessel stroke, coronary and peripheral artery disease and atherosclerotic aortic calcification. The pro-atherogenic role of HDAC9 has been well established in …
-
The Role of Histone Deacetylase Inhibitors in Ameliorating Memory Dysfunction of an Alzheimer's Disease Mouse Model
… for systemic treatment with histone deacetylase (HDAC) inhibitors to ameliorate cognitive deficits in a mouse model of AD. Using the APPSwe/PS1dE9 mouse model of AD, we showed that giving HDAC inhibitors systemically for 3 weeks reversed contextual memory deficits, stably maintained memories over …
-
EPIGENETICS OF ENERGY METABOLISM: FOCUS ON CLASS I HISTONE DEACETYLASES
… inhibition of class I histone deacetylases (HDACs) in metabolic profile and functionality of key organs participating in energy metabolism. Cultured myotubes and primary brown adipocytes treated with a class I-specific HDAC inhibitor showed higher expression of Pgc-1α, increased mitochondrial …
-
Design, Synthesis, and Biological Characterization of Largazole Analogues
<p>Histone deacetylases (HDACs) have been shown to play key roles in tumorigenesis, and</p><p>have been validated as effective enzyme target for cancer treatment. Largazole, a marine natural</p><p>product isolated from the cyanobacterium Symploca, is an extremely potent HDAC inhibitor …
-
The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer
… tolerable and effective.</p> <p.the (dsb)="" (hdac)="" (hr)="" (mrn)="" (nhej),="" a="" aims="" and="" at="" bladder="" break="" cancer="" cell="" complex.<="" deacetylase="" determine="" dna="" double="" effects="" end="" for="" further="" goal="" histone="" homologous="" in="" inhibitor="" …
-
Erasing the eraser. The synthesis and biological evaluation of some novel epigenetic inhibitors.
… as potential drug targets. Histone deacetylases (HDACs) and Lysine Specific Demethylase 1 (LSD1) are two such targets that have received significant attention in recent times. Although both enzymes have been found to be crucial in several regulatory roles, their overexpression has been observed in …
-
Identification of substrate-selective histone deacetylases and their inhibitors that mediate HER2 transcript stability
… include the utilization of histone deacetylase (HDAC) inhibitors. It has been observed that HDAC inhibitors can induce the rapid decay of oncogenic transcripts such as the HER2 mRNA, though the mechanism underlying this process remains undefined. Earlier observations in our lab led to speculation …
Page 1 of 9